AKT1 and neoplasm: As observed in the cell lines, suppression of p-ERK was observed in all tumors independent of responsiveness, although one could argue there was a more robust effect in the most sensitive tumor, CUCRC114, with a TGII of −67% that was accompanied by a reduction in p-AKT.